QSAM Biosciences Inc. (OTCQB - QSAM) is built for multiple cancer therapy clinical trials for its novel bone cancer cells-killing therapy and we foresee a sale of the company in the cards as well.

With all the recent attention on vaccines, a brief sell-off in some COVID-19 testing stocks has presented a great entry opportunity as the pivot back to them occurs. In our view, Global Wholehealth Partners (OTC - GWHP) offers major upside.

After soaring past our price target form $0.063 to $0.33 in the last month, we are raising our target on Solar Integrated Roofing Corp. from $0.25 to $0.75

As a comp and peer to Airbnb through its wholly owned Vacaychella subsidiary, World Series of Golf, Inc. (OTC - WSGF) is positioned to enjoy huge share price growth in the near term as its low priced alternative and could reach our $0.20 target as future milestones are achieved.

Currently on a $25M revenue run-rate, Solar Integrated Roofing Corp. (OTC - SIRC) may offer the greatest upside of any company in the solar space. The stock trades at a big discount to its peers, and although it trades above its 50 and 200 DMAs, this underfollowed player hasn't yet enjoyed the big moves of its peers.

With its core business ahead of forecasts and business development accelerating its initiatives, we affirm our target price and project a marked share volume increase in IQST as well.

Electromedical Technologies, Inc. (OTCQB – EMED) is an FDA-cleared bioelectronics provider poised to introduce a new product that could drive exponential sales and serve as an alternative to opioids.

With two COVID-19 diagnostic test applications pending clearance at the FDA, Global Wholehealth Partners Corp. (OTC - GWHP) appears to be at a great entry point.

Telecom services provider iQSTEL, Inc. (OTC - IQST) is evolving, adding new markets and offerings which are driving growth beyond $40M in sales mark in 2020, and should take the valuation to new heights, even at a discount to its peer group.

We are raising our price target on Findit, Inc. (OTC - FDIT) by 20% due to stronger than expected traction with customers and what we believe will be a steady stream of new members/clients, including Goldman Small Cap Research.